PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 84.57 billion as of September 8, 2025. Its market cap has decreased by -15.53% in one year.

Market Cap

84.57B

Enterprise Value

89.91B

Revenue

171.66B

Ranking

n/a

PE Ratio

718.18

Stock Price

4,510.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 84.57B, an increase of 676.40%. That is a compound annual growth rate of 7.06%.

Market Cap History

Date	Market Cap	% Change
Sep 8, 2025	84.57B	14.00%
Dec 30, 2024	74.18B	-33.39%
Dec 28, 2023	111.36B	5.58%
Dec 29, 2022	105.47B	-33.88%
Dec 30, 2021	159.51B	-3.78%
Dec 30, 2020	165.78B	123.51%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.31T
Celltrion	37.23T
ALTEOGEN	25.41T
Yuhan	8,902.27B
SK Biopharmaceuticals	8,551.81B
Peptron	7,070.75B
PharmaResearch	6,545.48B
ABL Bio	5,621.23B

Market Cap Rankings